Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein IIb/IIIa antagonists for percutaneous coronary intervention

OBJECTIVE: Percutaneous coronary intervention (PCI) has become the most common mode of coronary revascularization. Inhibition of platelet aggregation via glycoprotein (GP) IIb/IIIa receptor blockade significantly reduces the acute ischemic complications associated with PCI, but the risk of bleeding...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Labinaz, Marino, Ho, Chuong, Banerjee, Srabani, Martin, Janet, Chen, Stella, Mensinkai, Shaila
Format: Artigo
Jezik:Inglês
Izdano: Pulsus Group Inc 2007
Teme:
Clinical Studies
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2651419/
https://ncbi.nlm.nih.gov/pubmed/17932572
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items